Better surgery starts with better visualization.

Modern surgery without replacing the surgeon.

Revelascope is a video-enabled surgical retractor integrating a camera and illumination directly into the retractor blade, developed for nipple-sparing mastectomy.

Revelascope is an investigational device under development by Crescata Surgical. Not yet evaluated or cleared by the FDA. Not available for clinical or commercial use.

The Problem

A surgeon is only as good as their retraction and their exposure.

University of Chicago Surgeon

Patient retraction trauma 5–14% skin-flap necrosis Tap to flip ↻

In order for the surgeon to achieve direct line-of-sight visualization, an assistant holds sustained tension on the skin flap. This forceful retraction is a recognized driver of skin flap and NAC necrosis, leading to post-operative complications.

Surgeon Injury >50% report career-affecting pain Tap to flip ↻

Dissecting with direct line-of-sight visualization forces non-anatomic and painful operating posture. Over the course of a surgical career, the cumulative physical strain causes chronic injury and early attrition.

Operative time Repositioning drives up operative time Tap to flip ↻

A usable view demands constant repositioning of the table, surgeon, and retractor. The added operative time is a resource burden on the entire OR team, and a cost the hospital absorbs.

Sources: Matsen et al., Ann Surg Oncol 2016; Epstein et al., JAMA Surg 2018; Davis et al., J Surg Res 2014; Hallbeck et al., Ann Surg Oncol 2020. Operative-time observations from Revelascope customer discovery interviews.

From Prototype to the OR

Each prototype development is validated with practicing breast surgeons before the next stage begins.

Nov 2025

Alpha prototype Bilateral cadaveric NSM completed with Revelascope as the sole retractor.

Aug 2026

Alpha-plus prototype In progress

Jan 2027

Beta prototype Validated with practicing breast surgeons before the OR.

Interested in where Revelascope goes next? Reach out to learn more about upcoming development milestones, or subscribe to our quarterly newsletter.

Get in touch

Send us a specific inquiry, or subscribe to follow Revelascope's development. Choose whichever fits.

Send an inquiry

Product inquiries, partnership, investment, donation, clinical collaboration, press, and/or careers. Leave a message and we'll get back to you.

Thanks — we'll be in touch.

Subscribe to the newsletter

Quarterly updates on prototype milestones, clinical validation, and company news. Just your email — no message needed.

You're subscribed — thanks.